Carnosine

Carnosine (beta-alanyl-L-histidine) is a naturally occurring dipeptide found at exceptionally high concentrations in long-lived, energy-intensive tissues: skeletal muscle (up to 20 mM in fast-twitch fibres), heart, and brain. First isolated by Russian chemist V. S. Gulevich in 1900, carnosine remained a biochemical curiosity for decades before systematic research beginning in the 1990s revealed its remarkable biological versatility. Today it occupies a unique position at the intersection of sports performance research and anti-aging science.

The primary physiological role of carnosine in skeletal muscle is pH buffering. During high-intensity exercise, glycolytic ATP production generates hydrogen ions (H+) that acidify muscle cytoplasm, impairing cross-bridge cycling and ultimately causing fatigue. Carnosine, with a pKa of 6.83, acts as an intramuscular buffer - accepting H+ to maintain pH and extending time to fatigue. Studies using phosphorus magnetic resonance spectroscopy (31P-MRS) have directly demonstrated that higher muscle carnosine levels correlate with better acidosis resistance during sprinting. Sprint athletes and strength athletes have dramatically higher muscle carnosine than endurance athletes or sedentary individuals. The pharmaceutical supplement beta-alanine, which increases muscle carnosine by 40-80% with 4-8 weeks of loading, has become one of the most evidence-supported ergogenic aids.

The anti-glycation properties of carnosine represent its most compelling longevity-related biology. Glycation - the non-enzymatic reaction of glucose and other reducing sugars with protein amino groups - produces advanced glycation end-products (AGEs) that accumulate in long-lived proteins (collagen, lens crystallins, elastin, myelin) and are major drivers of tissue aging, vascular disease, and diabetic complications. Carnosine acts as a "sacrificial" target for glycation: it reacts with glycating aldehydes (methylglyoxal, glyoxal, malondialdehyde) faster than most proteins, neutralising them before they can modify long-lived structural proteins. Importantly, glycated carnosine can then be cleaved by carnosinases and the freed amino acids recycled, making carnosine a regenerable anti-glycation shield.

The most striking biological property of carnosine was documented in classic cell biology experiments by Holliday and McFarlan in 1990: human fibroblasts cultured in media containing carnosine reached significantly more population doublings before reaching the Hayflick limit (replicative senescence) than control cells. Carnosine also reversed senescent cell morphology when cells approaching senescence were transferred to carnosine-containing media. The mechanisms appear to involve reduced telomere attrition, protection against mitochondrial dysfunction, and reduced accumulation of oxidised and glycated proteins in long-lived cells.

Carnosine's transition metal chelation provides an additional anti-oxidative mechanism. Cu2+ and Zn2+ ions, when free in the cytoplasm (as occurs in aging and neurodegeneration), catalyse the generation of hydroxyl radicals through Fenton chemistry. Carnosine forms stable complexes with both Cu2+ and Zn2+, reducing their pro-oxidant activity. In the context of Alzheimer's disease, this property is particularly relevant: amyloid-beta aggregation and toxicity are strongly facilitated by Cu2+ and Zn2+ coordination, and carnosine has been shown to inhibit copper-mediated amyloid aggregation and reduce amyloid toxicity in cell culture models.

The ophthalmic application of N-acetylcarnosine eye drops for cataracts represents one of the most intriguing clinical directions in carnosine research. The lens of the eye contains carnosine at high concentrations in youth, but carnosine levels decline dramatically with age while AGE accumulation and lens protein oxidation increase. Topical N-acetylcarnosine (which penetrates the corneal epithelium and is converted to carnosine inside the lens) has shown reversal of early lens opacification in multiple controlled trials, particularly in Russian and Chinese research centres, though these results remain under-replicated in Western settings.